Thomas Shrager

Thomas Shrager is a partner at Tweedy Browne, a renowned value investment firm based in New York City. With extensive experience in the financial sector, Shrager is known for his disciplined investment approach, focusing on undervalued companies and long-term performance. He emphasizes the importance of valuation in investment decisions, particularly in the context of current market fluctuations. Recently, he has been vocal about the attractiveness of European markets compared to the U.S., where he believes valuations have become unsustainable due to excessive fiscal policies. Shrager's insights on pharmaceutical companies, particularly Roche and Fresenius, highlight his commitment to fundamental analysis amidst political and economic uncertainties.